M&A Deal Summary |
|
|---|---|
| Date | 2015-01-07 |
| Target | Sequenta |
| Sector | Life Science |
| Buyer(s) | Adaptive Biotechnologies |
| Deal Type | Add-on Acquisition |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 2009 |
| Sector | Life Science |
Adaptive Biotechnologies Corp. is a diagnostic-driven company that leverages NGS to profile T-cell and B-cell Receptors. Adaptive helps researchers make discoveries in oncology, autoimmune disorders and infectious diseases by offering fee-for-service access to its proprietary immune profiling sequencing technology, which is now available to facilitate the integration of immunosequencing into research centers.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 1 |
| Sector: Life Science M&A | 1 of 1 |
| Type: Add-on Acquisition M&A Deals | 1 of 1 |
| State: California M&A | 1 of 1 |
| Country: United States M&A | 1 of 1 |
| Year: 2015 M&A | 1 of 1 |
